Aptevo Therapeutics EPS - Earnings per Share 2014-2022 | APVO
Aptevo Therapeutics eps - earnings per share from 2014 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Aptevo Therapeutics Annual EPS |
| 2021 |
$-6.07 |
| 2020 |
$-5.23 |
| 2019 |
$-13.86 |
| 2018 |
$-33.47 |
| 2017 |
$4.62 |
| 2016 |
$-77.73 |
| 2015 |
$-41.04 |
| 2014 |
$0.00 |
| 2013 |
$0.00 |
| Aptevo Therapeutics Quarterly EPS |
| 2022-03-31 |
$-1.55 |
| 2021-12-31 |
$-1.25 |
| 2021-09-30 |
$-1.43 |
| 2021-06-30 |
$-1.75 |
| 2021-03-31 |
$-1.64 |
| 2020-12-31 |
$-1.92 |
| 2020-09-30 |
$-2.10 |
| 2020-06-30 |
$-2.10 |
| 2020-03-31 |
$0.89 |
| 2019-12-31 |
$0.07 |
| 2019-09-30 |
$-2.15 |
| 2019-06-30 |
$-4.14 |
| 2019-03-31 |
$-7.64 |
| 2018-12-31 |
$-8.82 |
| 2018-09-30 |
$-7.70 |
| 2018-06-30 |
$-8.12 |
| 2018-03-31 |
$-8.82 |
| 2017-12-31 |
$-5.74 |
| 2017-09-30 |
$24.51 |
| 2017-06-30 |
$-7.42 |
| 2017-03-31 |
$-6.72 |
| 2016-12-31 |
$-10.22 |
| 2016-09-30 |
$-49.72 |
| 2016-06-30 |
$-8.82 |
| 2016-03-31 |
$-8.96 |
| 2015-12-31 |
$0.00 |
| 2015-09-30 |
$-8.82 |
| 2015-06-30 |
$-12.33 |
| 2014-12-31 |
$0.00 |
| 2013-12-31 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.022B |
$0.012B |
|
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
|
